.webp)
Key takeaways:
- Throughout 2025, Nerva collaborated with research teams at Mayo Clinic, Massachusetts General Hospital, Mount Sinai, Monash University, and an NHS Trust to advance brain-gut therapy evidence.
- The round-up summarizes published, presented, and ongoing studies spanning IBS, IBD in remission, upper-GI functional disorders, pelvic pain conditions, and mechanisms of change.
- The report highlights how DGBI care is evolving and where digital brain-gut tools can be referred in everyday clinical workflows.
- Clinicians interested in partnering on future studies or learning more about the research program can contact the Nerva team at healthcare@nervahealth.com.
Explore emerging insights across IBS, IBD in remission, upper-GI functional disorders, pelvic pain conditions, and mechanisms of change
Read Nerva's 2025 Research Round-Up
Throughout 2025, we collaborated with leading research teams to advance evidence in brain-gut therapy and DGBI management. Our partners included:
Mayo Clinic
